OTCMKTS:CTYX Curative Biotechnology (CTYX) Stock Price, News & Analysis $0.0096 +0.00 (+4.35%) As of 08/8/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Curative Biotechnology Stock (OTCMKTS:CTYX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Curative Biotechnology alerts:Sign Up Key Stats Today's Range$0.0080▼$0.009650-Day Range$0.0079▼$0.012952-Week Range$0.00▼$0.22Volume333,100 shsAverage Volume3.01 million shsMarket Capitalization$3.73 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Curative Biotechnology, Inc. engages in the provision of software solutions for the healthcare market. Its products include MedFlash, electronic Personal Health Manager, Medical Alert, personal emergency response services, product and medical transcription, disease management, revenue cycle management, and medical consulting-billing. The company was founded by Jon Pevzner on July 29, 1995 and is headquartered in Boca Raton, FL. Read More Receive CTYX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address CTYX Stock News HeadlinesBuy Rating Justified by Tenaya Therapeutics’ Promising Gene Therapy AdvancementsOctober 11, 2024 | markets.businessinsider.comCue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual MeetingOctober 4, 2024 | markets.businessinsider.comHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation. | Paradigm Press (Ad)CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer TreatmentAugust 29, 2024 | markets.businessinsider.comCurative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of DirectorsOctober 31, 2023 | tmcnet.comCurative Announces Spin-Off of Sensible Diagnostics with their Game-Changing 10-Minute Point-Of-Care PCR Testing PlatformMay 17, 2023 | finance.yahoo.comSOLVE FSHD Invests in Epic Bio to Advance Potentially Curative TherapyMay 16, 2023 | finance.yahoo.comCurative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop StudyJanuary 5, 2023 | wsj.comSee More Headlines CTYX Stock Analysis - Frequently Asked Questions How have CTYX shares performed this year? Curative Biotechnology's stock was trading at $0.0128 on January 1st, 2025. Since then, CTYX shares have decreased by 25.0% and is now trading at $0.0096. How do I buy shares of Curative Biotechnology? Shares of CTYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Curative Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Curative Biotechnology investors own include Universal Display (OLED), Curative Biotechnology (CUBT), Telenav (TNAV), Semiconductor Manufacturing International (SIUIF), Cellular Biomedicine Group (CBMG), ANADIGICS (ANAD) and Intec Pharma (NTEC). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Miscellaneous Health & Allied Services Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CTYX CIKN/A Webwww.connectyx.com Phone(561) 418-7725FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares388,504,000Free FloatN/AMarket Cap$3.73 million OptionableNot Optionable Beta-33.99 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:CTYX) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curative Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Curative Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
